twentyon
deriv
taxchinin
brevifoliol
synthes
evalu
cytotox
human
nonsmal
lung
cancer
cell
line
nine
deriv
show
potent
activ
ic
valu
lm
potent
deriv
ic
lm
respect
structureact
relationship
sar
compound
establish
exocycl
unsatur
keton
ring
c
key
structur
element
activ
bunsatur
keton
posit
ring
effect
activ
signific
cytotox
deriv
may
due
conform
chang
taxan
ring
studi
conduct
seri
compound
provid
optim
predict
compar
molecular
field
comfa
model
crossvalid
r
q
valu
paclitaxel
wellknown
antitumor
drug
novel
mechan
action
spur
isol
taxoid
plant
genu
taxu
includ
larg
number
abeotaxoid
skeleton
modif
studi
sar
taxoid
focus
paclitaxel
analog
skeleton
oxetan
ring
howev
knowledg
base
modif
biolog
activ
taxoid
skeleton
still
call
continu
enrich
taxchinin
isol
taxu
chinensi
first
natur
occur
taxoid
correctli
assign
anortaxan
skeleton
although
brevifoliol
first
natur
taxoid
anortaxan
skeleton
isol
leav
brevifolia
incorrectli
assign
system
also
isol
taxchinin
brevifoliol
leav
stem
chinensi
found
abund
taxoid
leav
stem
plant
fig
previou
public
brevifoliol
report
show
cytotox
cell
seri
brevifoliol
deriv
prepar
includ
introduct
acetyl
troc
nbenzoyl
phenyl
isoserin
te
group
howev
analog
show
littl
bioactiv
taxchinin
also
report
cytotox
kb
cell
modif
taxchinin
could
trace
michael
reaction
acceptor
function
olefin
acetylen
conjug
electronwithdraw
group
michael
reaction
acceptor
consid
class
biolog
activ
molecul
directli
indirectli
involv
life
process
regul
mani
signal
pathway
cell
play
import
role
chemic
biolog
studi
one
michael
acceptor
develop
treat
chaga
diseas
clinic
trial
anoth
michael
acceptor
ruprintrivir
enter
phase
ii
clinic
studi
human
potenti
nasal
deliv
antirhinovir
agent
moreov
michael
acceptor
inhibitor
base
structur
drew
intens
attent
treatment
sar
sever
acut
respiratori
syndrom
michael
acceptor
great
medic
interest
great
potenti
use
drug
novel
skeleton
abund
plant
taxchinin
brevifoliol
select
precursor
synthesi
taxoid
bunsatur
keton
moieti
deriv
michael
reaction
acceptor
propos
show
bioactiv
therefor
deriv
taxchinin
brevifoliol
consist
variou
unsatur
keton
ring
ring
c
design
synthes
total
synthet
compound
accompani
parent
compound
subject
cytotox
screen
human
nonsmal
lung
cancer
cell
line
sar
compound
discuss
comfa
analysi
perform
use
cytotox
data
synthet
procedur
biolog
assay
result
also
provid
herein
synthesi
deriv
taxchinin
brevifoliol
shown
scheme
scheme
oxid
pyridinium
dichrom
pdc
ch
cl
h
select
produc
could
obtain
h
compound
similar
except
absenc
acetoxi
group
howev
oxid
pdc
ch
cl
much
differ
oxid
pdc
h
gave
wherea
accompani
rearrang
product
obtain
h
rearrang
involv
pdc
oxid
first
report
mechan
difficult
explain
attempt
prepar
unsuccess
obtain
strategi
select
protect
employ
although
attempt
prepar
deriv
chlorotriethylsilan
tescl
gave
te
taxchinin
chinin
obtain
along
byproduct
tbdm
taxchinin
treatment
tertbutylchlorodimethylsilan
tbdmscl
imidazol
n
ndimethylformamid
dmf
oxid
pdc
yield
deriv
treat
hfpyridin
pyridin
produc
desir
taxchinin
accompani
compound
scheme
synthes
report
inspir
us
prepar
treatment
tosylchlorid
tscl
yield
respect
oxid
pdc
afford
desir
product
oxid
gave
unexpect
deriv
rather
scheme
studi
chemistri
abeotaxan
found
group
abeotaxan
could
elimin
sodium
hydrid
nah
thf
employ
experi
access
taxoid
unsatur
keton
unit
react
nah
thf
elimin
group
acetoxi
group
occur
produc
treatment
nah
thf
gave
treat
nah
yield
oxid
produc
scheme
cytotox
compound
evalu
cell
line
anticanc
drug
cisplatin
ddp
use
refer
compound
shown
tabl
nine
deriv
exhibit
remark
activ
ic
valu
lm
taxchinin
deriv
show
activ
deriv
deriv
exhibit
potent
activ
ic
valu
lm
respect
moreov
te
deriv
deriv
tbdm
deriv
show
activ
deriv
exhibit
potent
activ
ic
lm
compound
possess
tetrahydrofuran
ring
moieti
exhibit
activ
howev
deriv
show
potent
activ
ic
lm
taxchinin
deriv
brevifoliol
deriv
inact
brevifoliol
oxid
carbonyl
group
found
activ
moreov
deriv
show
activ
oxid
product
exhibit
margin
activ
deriv
taxchinin
brevifoliol
show
moder
good
activ
compound
without
exocycl
unsatur
keton
ring
c
show
activ
result
indic
exocycl
unsatur
keton
ring
c
key
structur
element
activ
deriv
contain
unit
present
potent
activ
bunsatur
keton
posit
ring
effect
activ
moreov
introduct
doubl
bond
molecul
gave
remark
advantag
activ
certain
deriv
possess
unsatur
aldehyd
group
ring
c
show
weak
activ
addit
notic
potent
deriv
among
seri
compound
ic
lm
respect
show
sixand
fourfold
less
activ
ic
lm
signific
cytotox
taxchinin
may
due
conform
chang
taxan
ring
reflect
certain
key
jcoupl
coupl
constant
import
descriptor
shape
taxoid
serv
report
dihedr
angl
along
bottom
portion
b
ring
among
obtain
taxoid
compound
show
similar
coupl
constant
tabl
compound
j
hz
hz
suggest
might
similar
conform
differ
deriv
studi
compound
employ
comfa
analysi
analys
compound
unasterisk
molecul
tabl
select
train
set
model
construct
remain
compound
asterisk
molecul
tabl
test
set
model
valid
inhibit
constant
express
pic
valu
pic
ic
correl
steric
electrostat
field
comfa
compound
train
set
comfa
result
summar
tabl
crossvalid
leaveoneout
option
sampl
program
carri
obtain
optim
number
compon
use
final
analysi
optim
number
compon
four
determin
noncrossvalid
analysi
per
form
q
crossvalid
r
spress
crossvalid
standard
error
predict
r
noncrossvalid
r
f
valu
comput
accord
definit
sybyl
statist
index
reason
high
indic
comfa
model
strong
predict
abil
plot
experiment
result
versu
predict
valu
studi
compound
shown
figur
rel
contribut
comfa
model
steric
field
electrostat
field
evalu
predict
abil
model
subsequ
calcul
pic
valu
five
compound
test
set
seen
tabl
figur
calcul
valu
use
construct
comfa
model
good
agreement
experiment
data
model
exhibit
good
predict
abil
r
evalu
whether
result
bias
toward
select
train
set
also
perform
addit
comfa
studi
compound
includ
analysi
result
crossvalid
r
similar
rel
contribut
steric
electrostat
field
tabl
fig
comfa
result
usual
repres
contour
map
show
region
variat
steric
electrostat
natur
structur
featur
differ
molecul
contain
train
set
lead
increas
decreas
activ
comfa
steric
field
present
contour
plot
figur
aid
visual
compound
display
map
refer
structur
huge
steric
favor
region
fig
green
contour
locat
near
atom
suggest
bulki
group
area
would
increas
cytotox
yellow
region
indic
bulki
substitut
near
atom
favor
activ
comfa
electrostat
contour
map
shown
figur
aid
visual
compound
display
map
refer
structur
big
blue
polyhedron
near
atom
indic
posit
charg
region
play
favor
role
improv
cytotox
two
small
red
polyhedra
surround
atom
suggest
neg
charg
substitu
area
lead
increas
cytotox
tabl
deriv
interest
show
exocycl
unsatur
keton
ring
c
key
structur
element
activ
bunsatur
keton
posit
ring
effect
activ
moreov
taxchinin
potent
deriv
among
seri
compound
ic
lm
respect
may
due
conform
chang
taxan
ring
reflect
key
jcoupl
investig
sar
util
comfa
method
carri
result
model
provid
invalu
tool
design
cytotox
compound
employ
result
design
synthesi
cytotox
evalu
ongo
laboratori
result
report
due
cours
compound
mg
mmol
dissolv
n
ndimethylformamid
ml
solut
ad
tertbutylchlorodimethylsilan
mg
mmol
imidazol
mg
mmol
reaction
mixtur
stir
h
room
temperatur
start
materi
consum
mixtur
dilut
ethyl
acet
wash
water
brine
organ
layer
dri
na
concentr
residu
purifi
column
chromatographi
petroleum
ethyl
acet
give
mg
mg
taxchinin
titl
compound
synthes
yield
procedur
white
amorph
powder
petroleumethyl
acet
convers
compound
taxchinin
mg
mmol
dissolv
dri
pyridin
ml
solut
ad
ptoluenesulfonyl
chlorid
mg
mmol
reaction
mixtur
stir
room
temperatur
monitor
tlc
start
materi
consum
reaction
mixtur
dilut
ethyl
acet
wash
dilut
hydrochlor
acid
water
brine
organ
layer
dri
na
concentr
vacuo
residu
purifi
column
chromatographi
petroleumethyl
acet
steric
electrostat
interact
calcul
use
carbon
atom
steric
probe
charg
electrostat
probe
tripo
forc
field
comfa
grid
space
x
z
direct
default
valu
kcalmol
set
maximum
steric
electrostat
energi
cutoff
minimumsigma
column
filter
set
kcal
mol
regress
analysi
carri
use
full
crossvalid
partial
leastsquar
pl
method
leaveoneout
comfa
standard
option
scale
variabl
final
model
noncrossvalid
convent
analysi
develop
optimum
number
compon
equal
yield
highest
q
